What are NK Immune Cells and Keycell: Innovations in Body's Natural Defense

Quick answer

NK cells (Natural Killer cells) are innate immune cells primarily responsible for eliminating abnormal cells and foreign substances. Keycell-IM is EHL BIO’s innovative immune cell product, extracted from the patient's own blood and cultured using advanced technology for therapeutic use.

Key takeaways

NK cells quickly detect and eliminate deteriorated or abnormal cells within the body.
Keycell-IM utilizes Apheresis technology, capable of harvesting 30 times more cells than standard methods.
Immune cell therapy helps reduce disease recurrence and improves quality of life.
EHL BIO develops the integration of multiple immune cell types for maximum therapeutic efficiency.

Importance of the Immune System and NK Cells

The immune system acts as a biological defense mechanism against external foreign substances and internal agents. Its primary role is to eliminate abnormal and aging cells to maintain overall health. Insufficient immune function can lead to chronic infections, while overactivity may cause allergies.

NK cells (Natural Killer cells) belong to the innate immune cell group, serving as the first line of defense to detect and engulf foreign invaders and rapidly destroy abnormal cells. Maintaining the balance of these cells is the core of regenerative medicine for achieving quality of life and longevity, or 'Aging Well,' which is the central goal of EHL BIO.

Keycell-IM: EHL BIO’s Innovative Cell Therapy

Keycell-IM Inj. is an autologous immune cell product extracted from the patient’s own blood, then isolated and cultured using EHL BIO’s proprietary technology for maximum safety. The highlight of this innovation is the use of Apheresis technology, which enables the harvesting of 30 times more cells than conventional blood draws.

This process allows a single blood collection to be divided into 6-12 treatment sessions, effectively reducing the physical burden and time for patients. Keycell-IM is designed to reintroduce high-quality immune cells into the body to eliminate residual abnormal cells and prevent disease recurrence, focusing on enhancing health from within under international manufacturing standards.

Immune cell therapy utilizes the body's natural defense to create new opportunities for safe and precise health restoration.

GMP Manufacturing Standards and Cell Storage

EHL BIO prioritizes quality and safety at every production stage. Our cell culture facilities are GMP-certified (Good Manufacturing Practices) by the Ministry of Food and Drug Safety (MFDS) and were the first in Korea to be licensed as a Human Cell Management Business. The research center features Class 100 facilities and HEPA Filter systems to ensure maximum cleanliness.

Furthermore, we employ advanced cryopreservation technology at -196°C, which perfectly maintains cell viability and potency. This ensures that patients receive immune cells that are fully functional and effective. This technology is a vital component in developing sustainable regenerative medicine for the future.

Therapeutic Goals and Expected Outcomes

Immune cell therapy, particularly utilizing NK cells and Keycell-IM, is currently in the stage of medical development as a method for body restoration from degeneration and various diseases. The primary goal is to minimize side effects from conventional treatments and increase the efficiency of clearing abnormal cells from the circulatory system.

The combined use of multiple immune cell types (such as T cells, NK cells, and Dendritic cells) is a new technique in Korea that EHL BIO is actively developing for superior clinical outcomes. However, each individual's treatment plan is subject to evaluation by EHL BIO’s medical and scientific teams to ensure alignment with personal health conditions and needs, focusing on long-term quality of life enhancement.

Frequently asked questions

How do NK cells differ from other immune cells?

NK cells are part of the innate immune system, responding rapidly to eliminate abnormal cells without waiting for antigen recognition, unlike T cells or B cells which are acquired immune cells.

Is the Keycell-IM collection process painful?

The process involves standard blood collection or advanced Apheresis equipment to isolate specific immune cells, which is highly safe and minimizes physical burden on the patient.

Who researches and develops this technology?

EHL BIO’s team of expert physicians and scientists, led by CEO MD Hong-gi Lee, developed these international-standard cell culture and cryopreservation technologies.